版本:
中国

BRIEF-DiaMedica presents updated positive dm199 phase 1b trial identifying a superior subcutaneous delivery profile

March 13 DiaMedica Therapeutics Inc-

* DiaMedica presents updated positive dm199 phase 1b trial identifying a superior subcutaneous delivery profile

* DiaMedica Therapeutics Inc says no treatment-limiting adverse events were reported in any dose group Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐